Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 0.55 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.50 |
| ▸ | APP | P05067 | 3/20 | 0.49 |
| ▸ | GRM5 | P41594 | 1/20 | 0.48 |
| ▸ | CHAT | P28329 | 3/20 | 0.42 |
| ▸ | SNCA | P37840 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2845206 | 1.00 | RELA (0.55) | RELANFE2L2TRPA1APPGRM5 | |
| SCHEMBL29808641 | 0.98 | RELA (0.53) | RELANFE2L2TRPA1APPGRM5 | |
| SCHEMBL29523356 | 0.89 | GSK3B (0.44) | RELANFE2L2TRPA1APP | |
| SCHEMBL2776337 | 0.86 | APP (0.67) | RELAAPPSNCAMAOB | |
| SCHEMBL2776332 | 0.86 | APP (0.67) | RELAAPPSNCAMAOB | |
| SCHEMBL4072573 | 0.85 | MAPT (0.55) | RELAAPPGRM5 | |
| SCHEMBL4107791 | 0.85 | RELA (0.48) | RELANFE2L2TRPA1APPGRM5 | |
| SCHEMBL8359207 | 0.83 | CHAT (0.60) | APPCHAT | |
| SCHEMBL4586005 | 0.83 | NFE2L2 (0.54) | RELANFE2L2TRPA1APPCHAT | |
| SCHEMBL2775543 | 0.82 | APP (0.46) | RELANFE2L2APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 365 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3262055-B1 | WATER SOLUBLE FLUORESCENT OR COLORED DYES COMPRISING CONJUGATING GROUPS | SONY GROUP CORP (JP) | 2026-04-22 | — | — | EP | claimed |
| EP-4137818-B1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | SONY GROUP CORP (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-3440136-B1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | SONY GROUP CORP (JP) | 2025-07-23 | — | — | EP | claimed |
| US-12359071-B2 | Polymeric tandem dyes with linker groups | Sony Group Corporation (JP) | 2025-07-15 | — | — | US | claimed |
| WO-2025047293-A1 | COMPOUND, DETECTION SYSTEM, AND MEASUREMENT DEVICE | ソニーグループ株式会社 | 2025-03-06 | — | — | WO | claimed |
| US-20250009786-A1 | AUTOMATED SYNTHESIS OF POLYMERIC DUAL DRUGS | Sony Group Corporation (JP) | 2025-01-09 | — | — | US | claimed |
| US-20250009898-A1 | PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT | SONY GROUP CORP (JP) | 2025-01-09 | — | — | US | claimed |
| US-20240294767-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | SONY GROUP CORP (JP) | 2024-09-05 | — | — | US | claimed |
| EP-4408473-A1 | AUTOMATED SYNTHESIS OF POLYMERIC DUAL DRUGS | Sony Group Corporation (JP) | 2024-08-07 | — | — | EP | claimed |
| US-20240210408-A1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | SONY GROUP CORP (JP) | 2024-06-27 | — | — | US | claimed |
| EP-3019559-A1 | WATER SOLUBLE FLUORESCENT OR COLORED DYES AND METHODS FOR THEIR USE | Sony Corporation (JP) | 2016-05-18 | — | — | EP | claimed |
| WO-2015027176-A1 | WATER SOLUBLE FLUORESCENT OR COLORED DYES AND METHODS FOR THEIR USE | SONY CORPORATION (JP) | 2015-02-26 | — | — | WO | claimed |
| US-8268977-B2 | Strongly quenching oligomeric excimer/quencher pairs for detection schemes | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2012-09-18 | — | — | US | claimed |
| US-20100129820-A1 | STRONGLY QUENCHING OLIGOMERIC EXCIMER/QUENCHER PAIRS FOR DETECTION SCHEMES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-05-27 | — | — | US | claimed |
| US-7423133-B2 | Fluorescent glycosides and methods for their use | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2008-09-09 | — | — | US | claimed |
| US-20040215012-A1 | FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2004-10-28 | — | — | US | claimed |
| WO-2004019002-A2 | FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2004-03-04 | — | — | WO | claimed |
| EP-0026088-B1 | PHOTORESIST COMPOSITIONS | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1983-11-23 | — | — | EP | claimed |
| US-4349619-A | CONTAINING ANTIHALATION AGENTS | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1982-09-14 | — | — | US | claimed |
| EP-0026088-A2 | Photoresist compositions | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1981-04-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12359071-B2 | Polymeric tandem dyes with linker groups | CHRM1, IK, TMT1A | RELA 1536/4885NFE2L2 3516/4885TRPA1 906/4885 |
| US-20250009898-A1 | PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT | CHRM1, TPD52L2, H1-3 | RELA 1765/4885NFE2L2 4026/4885TRPA1 3918/4885 |
| US-20250009786-A1 | AUTOMATED SYNTHESIS OF POLYMERIC DUAL DRUGS | CHRM1, CHRM2, H1-0 | RELA 1772/4885NFE2L2 4589/4885TRPA1 3332/4885 |
| US-20100129820-A1 | STRONGLY QUENCHING OLIGOMERIC EXCIMER/QUENCHER PAIRS FOR DETECTION SCHEMES | PNKP, TK1, WRN | RELA 2425/4885NFE2L2 2693/4885TRPA1 2176/4885 |
| US-20240294767-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | CHRM1, IK, TMT1A | RELA 1536/4885NFE2L2 3516/4885TRPA1 906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.